Compare PTLE & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTLE | ADXN |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | Singapore | Switzerland |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8M | 10.3M |
| IPO Year | 2024 | N/A |
| Metric | PTLE | ADXN |
|---|---|---|
| Price | $0.13 | $8.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 742.9K | 8.1K |
| Earning Date | 11-03-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $91,415,732.00 | $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.10 | $6.51 |
| 52 Week High | $14.55 | $12.05 |
| Indicator | PTLE | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 52.53 |
| Support Level | $0.10 | $7.00 |
| Resistance Level | $0.12 | $10.43 |
| Average True Range (ATR) | 0.01 | 0.53 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 66.03 | 38.78 |
PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.